Stella Diagnostics, Inc. (SLDX)
OTCMKTS · Delayed Price · Currency is USD
0.0300
-0.0050 (-14.29%)
At close: Aug 6, 2025
Stella Diagnostics Market Cap
Stella Diagnostics has a market cap or net worth of $10.40 million as of August 8, 2025. Its market cap has decreased by -73.36% in one year.
Market Cap
10.40M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since July 7, 2008, Stella Diagnostics's market cap has increased from 15.00 to 10.40M, an increase of 69,300,986.67%. That is a compound annual growth rate of 119.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 10.40M | -39.80% |
| Dec 23, 2024 | 17.27M | 29.13% |
| Dec 29, 2023 | 13.37M | -44.17% |
| Dec 20, 2022 | 23.95M | -38.61% |
| Dec 30, 2021 | 39.02M | -11.01% |
| Dec 29, 2020 | 43.85M | 878.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.57M |
| Glass House Brands | 474.59M |
| Northwest Biotherapeutics | 368.08M |
| CytoDyn | 337.23M |
| American Oncology Network | 330.70M |